Yanggu Huatai Chemical’s acquisition review suspended by SZSE

Shandong Yanggu Huatai Chemical Co., Ltd. announced on September 30, 2025, that the Shenzhen Stock Exchange (SZSE) has suspended the review of its proposed acquisition. The transaction involves acquiring 99.64% of Bomi Technology Co., Ltd. through a combination of share issuance and cash payment, alongside a private placement of supporting funds.

The suspension stems from the expiry of the financial data in the company's major asset restructuring application file, which was based on a benchmark date of December 31, 2024. As per SZSE rules, the company is required to submit updated financial information.

The company states this suspension will not materially impact the overall transaction. It is coordinating with intermediaries to expedite the additional auditing work and update the financial data, aiming to resume the review process promptly. The company also reminds investors of the inherent uncertainties in obtaining regulatory approvals.